検索
検索条件の追加:
検索条件を追加することで検索結果を絞り込むことができます。
検索結果表示: 1-5 / 5.
- 前
- 1
- 次
検索結果:
| 書誌情報 | ファイル |
|---|---|
| Efficacy and safety of canagliflozin in combination with insulin: A double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus Inagaki, Nobuya; Harashima, Shin ichi; Maruyama, Nobuko; Kawaguchi, Yutaka; Goda, Maki; Iijima, Hiroaki (2016-06-18) Cardiovascular Diabetology, 15 |  |
| Long-term efficacy and safety of canagliflozin in combination with insulin in Japanese patients with type 2 diabetes mellitus Inagaki, Nobuya; Harashima, Shin-ichi; Kaku, Kohei; Kondo, Kazuoki; Maruyama, Nobuko; Otsuka, Makiko; Kawaguchi, Yutaka; Iijima, Hiroaki (2018-04-01) Diabetes, Obesity and Metabolism, 20(4): 812-820 | |
| Long-term safety and efficacy of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes Kadowaki, Takashi; Inagaki, Nobuya; Kondo, Kazuoki; Nishimura, Kenichi; Kaneko, Genki; Maruyama, Nobuko; Nakanishi, Nobuhiro; Watanabe, Yumi; Gouda, Maki; Iijima, Hiroaki (2018-01) Diabetes, Obesity and Metabolism, 20(1): 77-84 | |
| Intra- and inter-subject variability for increases in serum ketone bodies in patients with type 2 diabetes treated with the sodium glucose co-transporter 2 inhibitor canagliflozin Polidori, David; Iijima, Hiroaki; Goda, Maki; Maruyama, Nobuko; Inagaki, Nobuya; Crawford, Peter A. (2018-05) Diabetes, Obesity and Metabolism, 20(5): 1321-1326 | |
| Efficacy and safety of canagliflozin as add-on therapy to a glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: A 52-week, open-label, phase IV study Harashima, Shin ichi; Inagaki, Nobuya; Kondo, Kazuoki; Maruyama, Nobuko; Otsuka, Makiko; Kawaguchi, Yutaka; Watanabe, Yumi (2018-07) Diabetes, Obesity and Metabolism, 20(7): 1770-1775 | |